Monoamine oxidase A gene polymorphisms and enzyme activity associated with risk of gout in Taiwan aborigines

[1]  叶夏,et al.  Gout , 2011 .

[2]  Duk-Hee Kang,et al.  Uric acid and cardiovascular risk. , 2008, The New England journal of medicine.

[3]  T. Merriman,et al.  Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. , 2008, Rheumatology.

[4]  I. Hisatome,et al.  Plasma Urate Level Is Directly Regulated by a Voltage-driven Urate Efflux Transporter URATv1 (SLC2A9) in Humans* , 2008, Journal of Biological Chemistry.

[5]  A. Taniguchi,et al.  Control of renal uric acid excretion and gout , 2008, Current opinion in rheumatology.

[6]  B. Rutkowski,et al.  Uric Acid Excretion and Dopamine-Induced Glomerular Filtration Response in Patients with IgA Glomerulonephritis , 2007, American Journal of Nephrology.

[7]  P. Jose,et al.  The dopaminergic system in hypertension. , 2007, Clinical science.

[8]  M. Perdiguero,et al.  Gout, diuretics and the kidney , 2006, Annals of the rheumatic diseases.

[9]  Hyon K. Choi,et al.  Pathogenesis of Gout , 2005, Annals of Internal Medicine.

[10]  M. Hediger,et al.  Molecular physiology of urate transport. , 2005, Physiology.

[11]  R. Terkeltaub.  Clinical practice. Gout. , 2003, The New England journal of medicine.

[12]  A. Parini,et al.  Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. , 2003, Journal of the American Society of Nephrology : JASN.

[13]  Doron Lancet,et al.  Evidence for positive selection and population structure at the human MAO-A gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Soares-da-Silva,et al.  Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  A. Parini,et al.  Reactive oxygen species production by monoamine oxidases in intact cells , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  P. Soares-da-Silva,et al.  The activity of MAO A and B in rat renal cells and tubules. , 1998, Life sciences.

[17]  Y. Ko,et al.  High prevalence of gout and related risk factors in Taiwan's Aborigines. , 1997, The Journal of rheumatology.

[18]  B. Emmerson.  The management of gout. , 1997, The New England journal of medicine.

[19]  P. Gaspar,et al.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. , 1995, Science.

[20]  F. Cappuccio,et al.  Uric acid metabolism and tubular sodium handling. Results from a population-based study. , 1993, JAMA.

[21]  R. Felder,et al.  The renal dopamine receptors. , 1992, Journal of the American Society of Nephrology : JASN.

[22]  D. Mccarty,et al.  Preliminary criteria for the classification of the acute arthritis of primary gout. , 1977, Arthritis and rheumatism.

[23]  S. Benner,et al.  The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease. , 2008, Medical hypotheses.

[24]  Y. Ko,et al.  Complex segregation and linkage analysis of familial gout in Taiwanese aborigines. , 2004, Arthritis and rheumatism.

[25]  A. Parini,et al.  Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase. , 2001, Kidney international.

[26]  A. Stern,et al.  Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. , 1996, Free radical biology & medicine.

[27]  M. H. Fernandes,et al.  Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine. , 1994, Journal of neural transmission. Supplementum.

[28]  O. Kunduzova,et al.  The FASEB Journal express article 10.1096/fj.01-1008fje. Published online May 21, 2002. Regulation of JNK/ERK activation, cell apoptosis, and , 2022 .